Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR1 | Q92633 | 9/20 | 0.68 |
| ▸ | LPAR3 | Q9UBY5 | 9/20 | 0.68 |
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.68 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | TLR2 | O60603 | 4/20 | 0.53 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.52 |
| ▸ | PRKCG | P05129 | 1/20 | 0.52 |
| ▸ | PRKCB | P05771 | 1/20 | 0.52 |
| ▸ | PRKCA | P17252 | 1/20 | 0.52 |
| ▸ | PRKCH | P24723 | 1/20 | 0.52 |
| ▸ | PRKCI | P41743 | 1/20 | 0.52 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.52 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.52 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.52 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.52 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.52 |
| ▸ | LPAR6 | P43657 | 5/20 | 0.50 |
| ▸ | LPAR4 | Q99677 | 5/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7183039 | 1.00 | LPAR1 (0.68) | LPAR1LPAR3LPAR2DNM1USP2 | |
| SCHEMBL30510651 | 1.00 | LPAR1 (0.68) | LPAR1LPAR3LPAR2DNM1USP2 | |
| SCHEMBL30910033 | 1.00 | LPAR1 (0.68) | LPAR1LPAR3LPAR2DNM1USP2 | |
| SCHEMBL30510614 | 1.00 | LPAR1 (0.68) | LPAR1LPAR3LPAR2DNM1USP2 | |
| SCHEMBL4294185 | 1.00 | LPAR1 (0.68) | LPAR1LPAR3LPAR2DNM1USP2 | |
| SCHEMBL8636551 | 1.00 | LPAR1 (0.68) | LPAR1LPAR3LPAR2DNM1USP2 | |
| SCHEMBL303128 | 1.00 | LPAR1 (0.68) | LPAR1LPAR3LPAR2DNM1USP2 | |
| SCHEMBL7563995 | 1.00 | LPAR1 (0.68) | LPAR1LPAR3LPAR2DNM1USP2 | |
| SCHEMBL4879843 | 1.00 | LPAR1 (0.68) | LPAR1LPAR3LPAR2DNM1USP2 | |
| SCHEMBL4204708 | 1.00 | LPAR1 (0.68) | LPAR1LPAR3LPAR2DNM1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2031974-A1 | FATTY ACID TRIGLYCERIDES FOR MAKING BIOCOMPATIBLE COATINGS | Ziscoat N.V. (BE) | 2009-03-11 | — | — | EP | claimed |
| WO-2007131802-A1 | FATTY ACID TRIGLYCERIDES FOR MAKING BIOCOMPATIBLE COATINGS | ZISCOAT NV (BE) | 2007-11-22 | — | — | WO | claimed |
| EP-2817275-B1 | CONVERSION OF LIPIDS | DALIAN INST CHEM & PHYSICS CAS (CN) | 2023-09-13 | — | — | EP | disclosed |
| US-20150203417-A1 | CONVERSION OF LIPIDS | Dailan Institute of Chemical Physics Chinese Academy of Sciences (CN) | 2015-07-23 | — | — | US | disclosed |
| EP-2817275-A1 | CONVERSION OF LIPIDS | Dalian Institute Of Chemical Physics, Chinese Academy Of Sciences (CN) | 2014-12-31 | — | — | EP | disclosed |
| WO-2013123678-A1 | CONVERSION OF LIPIDS | DALIAN INSTITUTE OF CHEMICAL PHYSICS CHINESE ACADEMY OF SCIENCES (CN) | 2013-08-29 | — | — | WO | disclosed |
| US-8435547-B2 | Krebs cycle intermediate or precursor of Krebs cycle intermediate, pharmaceutically acceptable topical vehicle comprising a mitochondrial fuel or substance that is efficiently convertible to mitochondrial fuel by normal skin cell metabolism; for stimulating mitochondrial activity in skin cells | Blass, John P. (US) | 2013-05-07 | — | — | US | disclosed |
| WO-2008027063-A1 | ANTI-AGING SKIN PREPARATION | BLASS JOHN P (US) | 2008-03-06 | — | — | WO | disclosed |
| US-20080057088-A1 | Anti-aging cream | BLASS JOHN P | 2008-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150203417-A1 | CONVERSION OF LIPIDS | CETP, FAR1, SCD | LPAR1 409/4885LPAR3 675/4885LPAR2 789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.